Literature DB >> 11818555

Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation.

Lena Scott1, Maria Sol Kruse, Hans Forssberg, Hjalmar Brismar, Paul Greengard, Anita Aperia.   

Abstract

Glutamate, by activating N-methyl-d-aspartate (NMDA) receptors, alters the balance between dopamine D1 and D2 receptor signaling, but the mechanism responsible for this effect has not been known. We report here, using immunocytochemistry of primary cultures of rat neostriatal neurons, that activation of NMDA receptors recruits D1 receptors from the interior of the cell to the plasma membrane while having no effect on the distribution of D2 receptors. The D1 receptors were concentrated in spines as shown by colocalization with phalloidin-labeled actin filaments. The effect of NMDA on D1 receptors was abolished by incubation of cells in calcium-free medium and was mimicked by the calcium ionophore ionomycin. Recruitment of D1 receptors from the interior of the cell to the membrane was confirmed by subcellular fractionation. The recruited D1 receptors were functional as demonstrated by an increase in dopamine-sensitive adenylyl cyclase activity in membranes derived from cells that had been pretreated with NMDA. These results provide evidence for regulated recruitment of a G protein-coupled receptor in neurons, provide a cell biological basis for the effect of NMDA on dopamine signaling, and reconcile the conflicting hyperdopaminergic and hypoglutamatergic hypotheses of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818555      PMCID: PMC122247          DOI: 10.1073/pnas.032654599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction.

Authors:  S R Hirsch; I Das; L J Garey; J de Belleroche
Journal:  Pharmacol Biochem Behav       Date:  1997-04       Impact factor: 3.533

2.  Role of AMPA receptor cycling in synaptic transmission and plasticity.

Authors:  C Lüscher; H Xia; E C Beattie; R C Carroll; M von Zastrow; R C Malenka; R A Nicoll
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

3.  Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons.

Authors:  O Aizman; H Brismar; P Uhlén; E Zettergren; A I Levey; H Forssberg; P Greengard; A Aperia
Journal:  Nat Neurosci       Date:  2000-03       Impact factor: 24.884

4.  Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation.

Authors:  A Barria; D Muller; V Derkach; L C Griffith; T R Soderling
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 5.  The glutamatergic dysfunction hypothesis for schizophrenia.

Authors:  J T Coyle
Journal:  Harv Rev Psychiatry       Date:  1996 Jan-Feb       Impact factor: 3.732

6.  Ca(2+)-dependent exocytosis in the somata of dorsal root ganglion neurons.

Authors:  L Y Huang; E Neher
Journal:  Neuron       Date:  1996-07       Impact factor: 17.173

7.  Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.

Authors:  C Konradi; J C Leveque; S E Hyman
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

8.  Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.

Authors:  A R Mohn; R R Gainetdinov; M G Caron; B H Koller
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

9.  Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients.

Authors:  P Karlsson; L Smith; L Farde; C Härnryd; G Sedvall; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

10.  Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia.

Authors:  J A Den Boer; H J van Megen; W W Fleischhacker; J W Louwerens; B R Slaap; H G Westenberg; G D Burrows; O N Srivastava
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more
  41 in total

1.  Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.

Authors:  Lin Pei; Frank J S Lee; Anna Moszczynska; Brian Vukusic; Fang Liu
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

2.  Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex.

Authors:  Guojun Chen; Paul Greengard; Zhen Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

3.  Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines.

Authors:  Lena Scott; Sergey Zelenin; Seth Malmersjö; Jacob M Kowalewski; Eivor Zettergren Markus; Angus C Nairn; Paul Greengard; Hjalmar Brismar; Anita Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

4.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

5.  Preferential relocation of the N-methyl-D-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit.

Authors:  Y Hara; V M Pickel
Journal:  Neuroscience       Date:  2008-04-12       Impact factor: 3.590

Review 6.  Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications.

Authors:  H Ulrich; P Majumder
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

7.  Detection of cell surface dopamine receptors.

Authors:  Jiping Xiao; Clare Bergson
Journal:  Methods Mol Biol       Date:  2013

8.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

9.  Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.

Authors:  Paola Paoletti; Ingrid Vila; Maria Rifé; José Miguel Lizcano; Jordi Alberch; Silvia Ginés
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

10.  Repeated cocaine administration increases nitric oxide efflux in the rat dorsal striatum.

Authors:  Dong Kun Lee; Wei Choon Alvin Koh; Yoon-Bo Shim; Insop Shim; Eun Sang Choe
Journal:  Psychopharmacology (Berl)       Date:  2009-11-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.